Human colorectal cancer HCT-15 and SW620-14 cells were treated with MEK inhibitors, trametinib or U0126, combined with increasing concentrations of proteasome inhibitors, bortezomib or MG132. The gene discussed is MAP2K7; the disease is colorectal cancer.